Ganli Pharmaceutical: Xute Hongda plans to reduce its stake in the company by 0.57%.

Ganli Pharmaceuticals announced that Xute Hongda and its concerted action person Gan Zhongru collectively hold 40.11% of the company's shares, with Xute Hongda holding 5.90%. Xute Hongda plans to reduce its holdings by no more than 3.3995 million shares through centralized bidding trading within 3 months after the expiration of 15 trading days from the date of announcement, accounting for 0.57% of the total share capital of the company. Jiao Jiao intends to reduce holdings by no more than 67,500 shares, accounting for 0.0112% of the total share capital of the company. Sun Cheng plans to reduce holdings by no more than 20,000 shares, accounting for 0.0033% of the total share capital of the company. This reduction plan will not have any impact on the company's governance structure and sustainable operation.